Doesn't fuss me actually I am only focussed on the bottom line NPAT come report time, and EPS. I have previously stated I hold the opinion that with roll-ups EBITDA might be a key acquisition metric, but for market valuation purposes we need to see efficient fall of earnings to NPAT and EPS.
Cheers Gosouth
HLA Price at posting:
92.0¢ Sentiment: None Disclosure: Not Held